RIP3 A composition for anti-cancer adjuvant comprising a RIP3 expression inducing agent or activator

The present invention relates to an anti-cancer adjuvant pharmaceutical composition and an anti-cancer pharmaceutical composition for enhancing reactivity to anti-cancer drugs, which contain a receptor-interacting protein kinase-3 (RIP3) expression accelerator or activator as an active component. In...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: LEE, SANG HO, YOO, I SEUL, KIM, YOU SUN, NA, KYU HEUM, YOUM, JI HYUN, SEONG, SEUNG KYOO, WOO, JI YOUNG
Format: Patent
Sprache:eng ; kor
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!